BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12175472)

  • 1. Differential in vivo effects of H3 receptor ligands in a new mouse dipsogenia model.
    Fox GB; Pan JB; Esbenshade TA; Bitner RS; Nikkel AL; Miller T; Kang CH; Bennani YL; Black LA; Faghih R; Hancock AA; Decker MW
    Pharmacol Biochem Behav; 2002 Jun; 72(3):741-50. PubMed ID: 12175472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations.
    Krueger KM; Witte DG; Ireland-Denny L; Miller TR; Baranowski JL; Buckner S; Milicic I; Esbenshade TA; Hancock AA
    J Pharmacol Exp Ther; 2005 Jul; 314(1):271-81. PubMed ID: 15821027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of histamine H3 receptor ligands in experimental models of anxiety and depression.
    Pérez-García C; Morales L; Cano MV; Sancho I; Alguacil LF
    Psychopharmacology (Berl); 1999 Feb; 142(2):215-20. PubMed ID: 10102775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization.
    Fox GB; Pan JB; Radek RJ; Lewis AM; Bitner RS; Esbenshade TA; Faghih R; Bennani YL; Williams M; Yao BB; Decker MW; Hancock AA
    J Pharmacol Exp Ther; 2003 Jun; 305(3):897-908. PubMed ID: 12606600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed pharmacological characterization of GT-2331 for the rat histamine H3 receptor.
    Ito S; Yoshimoto R; Miyamoto Y; Mitobe Y; Nakamura T; Ishihara A; MacNeil DJ; Kanatani A; Tokita S
    Eur J Pharmacol; 2006 Jan; 529(1-3):40-6. PubMed ID: 16316645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proxyfan acts as a neutral antagonist of histamine H3 receptors in the feeding-related hypothalamic ventromedial nucleus.
    Clapp RH; Luckman SM
    Br J Pharmacol; 2012 Nov; 167(5):1099-110. PubMed ID: 22646302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects.
    Esbenshade TA; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Fox GB; Faghih R; Bennani YL; Williams M; Hancock AA
    J Pharmacol Exp Ther; 2003 Jun; 305(3):887-96. PubMed ID: 12606603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors.
    Rouleau A; Ligneau X; Tardivel-Lacombe J; Morisset S; Gbahou F; Schwartz JC; Arrang JM
    Br J Pharmacol; 2002 Jan; 135(2):383-92. PubMed ID: 11815373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist.
    Fox GB; Esbenshade TA; Pan JB; Radek RJ; Krueger KM; Yao BB; Browman KE; Buckley MJ; Ballard ME; Komater VA; Miner H; Zhang M; Faghih R; Rueter LE; Bitner RS; Drescher KU; Wetter J; Marsh K; Lemaire M; Porsolt RD; Bennani YL; Sullivan JP; Cowart MD; Decker MW; Hancock AA
    J Pharmacol Exp Ther; 2005 Apr; 313(1):176-90. PubMed ID: 15608077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of histamine H3-receptor ligands on brain monoamine oxidase in various mammalian species.
    Sakurai E; Sakurai E; Tanaka Y; Watanabe T; Singh Jossan S; Oreland L
    Brain Res; 2001 Jul; 906(1-2):180-3. PubMed ID: 11430877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligands for histamine H(3) receptors modulate cell proliferation and migration in rat oxyntic mucosa.
    Morini G; Grandi D; Schunack W
    Br J Pharmacol; 2002 Sep; 137(2):237-44. PubMed ID: 12208781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High antagonist potency of GT-2227 and GT-2331, new histamine H3 receptor antagonists, in two functional models.
    Tedford CE; Hoffmann M; Seyedi N; Maruyama R; Levi R; Yates SL; Ali SM; Phillips JG
    Eur J Pharmacol; 1998 Jun; 351(3):307-11. PubMed ID: 9721022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of R-alpha-methylhistamine, a selective histamine H3 receptor agonist, in rats: lack of involvement of histamine H3 receptors.
    Hegde SS; Chan P; Eglen RM
    Eur J Pharmacol; 1994 Jan; 251(1):43-51. PubMed ID: 7907986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the histamine H3 agonist (R)-alpha-methylhistamine and the antagonist thioperamide in vitro on monoamine oxidase activity in the rat brain.
    Sakurai E; Sakurai E; Maeyama K; Watanabe T; Jossan SS; Oreland L
    Methods Find Exp Clin Pharmacol; 1995 Nov; 17 Suppl C():46-50. PubMed ID: 8750795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.
    Parmentier R; Anaclet C; Guhennec C; Brousseau E; Bricout D; Giboulot T; Bozyczko-Coyne D; Spiegel K; Ohtsu H; Williams M; Lin JS
    Biochem Pharmacol; 2007 Apr; 73(8):1157-71. PubMed ID: 17288995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacement of imidazole by a piperidine moiety differentially affects the potency of histamine H3-receptor antagonists.
    Liedtke S; Flau K; Kathmann M; Schlicker E; Stark H; Meier G; Schunack W
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):43-50. PubMed ID: 12616340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for tolerance following repeated dosing in rats with ciproxifan, but not with A-304121.
    Pan JB; Yao BB; Miller TR; Kroeger PE; Bennani YL; Komater VA; Esbenshade TA; Hancock AA; Decker MW; Fox GB
    Life Sci; 2006 Aug; 79(14):1366-79. PubMed ID: 16730751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine H(3)-receptor antagonists inhibit gastroprotection by (R)-alpha-methylhistamine in the rat.
    Morini G; Grandi D; Stark H; Schunack W
    Br J Pharmacol; 2000 Apr; 129(8):1597-600. PubMed ID: 10780963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons.
    Dai H; Fu Q; Shen Y; Hu W; Zhang Z; Timmerman H; Leurs R; Chen Z
    Eur J Pharmacol; 2007 Jun; 563(1-3):117-23. PubMed ID: 17350613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of histamine receptor sub-types regulating prostacyclin release from human endothelial cells.
    Bull HA; Courtney PF; Rustin MH; Dowd PM
    Br J Pharmacol; 1992 Oct; 107(2):276-81. PubMed ID: 1330171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.